Showing results (21-30 of 425) with videos related to
Sort By:
Pageof 43
Seminars in Immunology|March 13, 2014
Clinical utility of natural killer cells in cancer therapy and transplantationDavid A Knorr, Veronika Bachanova, Michael R Verneris, et al.BMJ Open|August 7, 2016
Comparing the accuracy of quantitative versus qualitative analyses of interim PET to prognosticate Hodgkin lymphoma: a systematic review protocol of diagnostic test accuracyVít Procházka, Miloslav Klugar, Veronika Bachanova, et al.Clinical Lymphoma & Myeloma|November 15, 2006
Treatment of diffuse large B-cell lymphoma: a risk-based approachLaurie H Sehn, Joseph M ConnorsCurrent Opinion in Investigational Drugs (London, England : 2000)|July 2, 2005
Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignanciesHeather A Leitch, Joseph M ConnorsOncology (Williston Park, N.Y.)|June 7, 2005
Treatment of aggressive non-Hodgkin's lymphoma: a north American perspectiveLaurie H Sehn, Joseph M ConnorsJournal of Clinical Pharmacology|September 3, 2020
CD33-Targeted Therapies: Beating the Disease or Beaten to Death?Joseph E Maakaron, John Rogosheske, Meixiao Long, et al.Toxins|January 11, 2018
Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell MalignanciesJoerg U Schmohl, Deborah Todhunter, Elizabeth Taras, et al.Annals of Emergency Medicine|August 16, 2025
Major Adverse Events with Chimeric Antigen Receptor T-Cell Therapy: Presentation, Diagnosis, and ResuscitationKiril Dimitrov, Florian Merkle, Marketa Dimitrov, et al.Hematology/Oncology Clinics of North America|October 3, 2007
New strategies for the treatment of early stages of Hodgkin's lymphomaDavid A Macdonald, Joseph M ConnorsPageof 43